Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

AstraZeneca and Daiichi Sankyo's Enhertu Wins NMPA Approval in HER2‑Positive Early Breast Cancer – New Adjuvant Indication and Full Approval of Neoadjuvant Label in China
CompanyDrug

AstraZeneca and Daiichi Sankyo’s Enhertu Wins NMPA Approval in HER2‑Positive Early Breast Cancer – New Adjuvant Indication and Full Approval of Neoadjuvant Label in China

AstraZeneca plc (NYSE: AZN) and Daiichi Sankyo Company, Limited (TYO: 4568) announced that Enhertu (trastuzumab deruxtecan) has been approved by China's National Medical Products Administration (NMPA) for a new indication:…

Hansoh Pharmaceutical Resubmits Aumuletinib MAA to the EMA – EGFR‑TKI Application Validated for Two Advanced NSCLC Indications After EU Market Withdrawal

Hansoh Pharmaceutical Resubmits Aumuletinib MAA to the EMA – EGFR‑TKI Application Validated for Two Advanced NSCLC Indications After EU Market Withdrawal

Edding Genor's GB268 Wins NMPA IND Approval for Phase II Trial – PD‑1/CTLA‑4/VEGF Trispecific Antibody Plus Chemotherapy Targets First‑Line Advanced Colorectal Cancer

Edding Genor’s GB268 Wins NMPA IND Approval for Phase II Trial – PD‑1/CTLA‑4/VEGF Trispecific Antibody Plus Chemotherapy Targets First‑Line Advanced Colorectal Cancer

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Chongqing Zhifei Biological Launches Phase I Clinical Trial for Group B Meningococcal Vaccine

CompanyDrug

Kintor Pharmaceutical Initiates Long-Term Safety Trial for Androgenetic Alopecia Treatment KX-826

CompanyDrug

Antengene Initiates Phase I ERASER Study for ATG-017 in Combination with Nivolumab

CompanyDrug

Mabwell Bioscience’s 7MW3711 ADC for B7-H3 Gets Clinical Trial Approval in China

CompanyDrug

Shenzhen Salubris Pharmaceuticals Receives FDA Clearance for SAL0119 Clinical Trial

CompanyDrug

Bio-Thera Solutions Receives NMPA Approval for CTLA-4 and PD-1 Inhibitor Combo Study

CompanyDrug

Shanghai Pharmaceuticals Gets NMPA Green Light for Recombinant Human Adenovirus Type 5 Trial

CompanyDrug

Nanjing Immunophage Biotech’s IPG11406 Approved for SLE Clinical Trial in China

Show More